Probably we will have a very happy New Year: DCGI on COVID-19 vaccine

By: |
December 31, 2020 4:44 PM

India is likely to have a COVID-19 vaccine in the New Year, Drug Controller General of India V G Somani hinted on Thursday.

covid 19, ovid 19 vaccinesThe ministry said that 77.61 per cent of the new recovered cases are observed to be concentrated in 10 states and UTs.

India is likely to have a COVID-19 vaccine in the New Year, Drug Controller General of India V G Somani hinted on Thursday. Speaking at a webinar, Somani said the most important thing is that the industry and research organisations have stood the test of time. He said vaccine candidates have got the funding and also talked about the efforts made by the Department of Biotechnology. “…and probably we will have a very happy New Year with something in hand. That’s what I can hint at,” Somnai said.

The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval. Somani said the approval process was fast-tracked in view of the pandemic by quickly processing all applications, allowing parallel phase 1 and 2 trials without waiting for complete data. “There has been no compromise on the safety or efficacy of the data. The only thing is that the regulator has accepted partial data,” he said.

An expert panel in the Central Drugs Standard Control Organisation (CDSCO) that met on Wednesday to consider emergency use authorisation applications by SII for the Oxford COVID-19 vaccine and Bharat Biotech’s ‘Covaxin’ will reconvene on January 1 to further deliberate on the matter. The Subject Expert Committee (SEC) on COVID-19 on Wednesday deliberated and analysed the additional data and information submitted by the Serum Institute of India (SII) and Bharat Biotech.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
13,81,305 beneficiaries received COVID-19 vaccine, 580 adverse events reported: Health ministry
2India, China set to lead vaccine distribution in APAC region: Moody’s Analytics
3WHO: ‘Not right’ to vaccinate against COVID-19 young before old